Cargando…
A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease
BACKGROUND: Psychopharmacotherapy currently constitutes the first-line treatment for depression and anxiety in Parkinson’s disease (PD) however the efficacy of antidepressant treatments in PD is unclear. Several alternative treatments have been suggested as potentially more viable alternatives inclu...
Autores principales: | Troeung, Lakkhina, Egan, Sarah J., Gasson, Natalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827386/ https://www.ncbi.nlm.nih.gov/pubmed/24236141 http://dx.doi.org/10.1371/journal.pone.0079510 |
Ejemplares similares
-
A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease
por: Troeung, Lakkhina, et al.
Publicado: (2014) -
SEX/GENDER DIFFERENCES IN SERVICE USE PATTERNS, CLINICAL OUTCOMES AND MORTALITY RISK FOR ADULTS WITH ACQUIRED BRAIN INJURY: A RETROSPECTIVE COHORT STUDY (ABI-RESTART)
por: MANN, Georgina, et al.
Publicado: (2023) -
Prevalence, Patterns, and Predictors of Multimorbidity in Adults With Acquired Brain Injury at Admission to Staged Community-Based Rehabilitation
por: Jackson, Hayley M., et al.
Publicado: (2020) -
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
por: Möller, Hans-Jürgen, et al.
Publicado: (2017) -
Cohort profile: the Acquired Brain Injury Community REhabilitation and Support Services OuTcomes CohoRT (ABI-RESTaRT), Western Australia, 1991–2020
por: Mann, Georgina, et al.
Publicado: (2021)